JAPMA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, P. J.
Right arrow Articles by Kushner, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, P. J.
Right arrow Articles by Kushner, D.
Journal of the American Podiatric Medical Association
Volume 96 Number 4 318-322 2006
Copyright © 2006 American Podiatric Medical Association

Effect of a Nitroglycerin Patch on Perfusion to the Foot in Healthy Subjects

Paul Jeong Kim, DPM *, L. Clay Ballinger, DPM {dagger} and Donald Kushner, DPM {ddagger}

* Arizona Podiatric Medicine Program, Midwestern University College of Health Sciences, Glendale.
{dagger} Department of Podiatry, Scripps Mercy Hospital, San Diego, CA.
{ddagger} Department of Podiatry, Ohio College of Podiatric Medicine, Cleveland.

Corresponding author: Paul Jeong Kim, DPM, Arizona Podiatric Medicine Program, Midwestern University College of Health Sciences, 19555 N 59th Ave, Glendale, AZ 85308.

Abstract

Nitric oxide is an endogenous gas released by endothelial cells that induces vasodilatation and plays other important roles in the wound-healing process. Nitroglycerin preparations are liberators of nitric oxide. Podiatric physicians have used nitroglycerin paste and patches on patients in an attempt to increase perfusion to the foot. However, the drug’s efficacy seems to be largely anecdotal. A prospective, randomized, placebo-controlled, double-blind study was conducted to investigate the efficacy of a nitroglycerin patch in locally increasing perfusion to the foot. Twenty-two healthy subjects were randomly assigned to either a drug group (nitroglycerin patch, 0.2 mg/h) or a placebo group (adhesive patch without active ingredient). The patch was applied to the plantar arch of the foot. Objective and subjective measures were then used to detect changes in perfusion to the foot after a 2-hour experimental period. The objective measures, cutaneous thermometry and photoplethysmography, found no significant measurable difference in perfusion to the foot between the drug and placebo groups (P > .05). A subjective questionnaire used to assess changes in temperature or sensation detected by the subject yielded similar results. Thus a nitroglycerin patch dose of 0.2 mg/h showed no measurable ability to increase perfusion to the foot. Further research is needed to validate the indications for this therapy. (J Am Podiatr Med Assoc 96(4): 318–322, 2006)






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Podiatric Medical Association.